| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | | Total Revenue | 16,073 | 17,735 | 11,280 | 74,822 | | Cost of Revenue | 17,018 | 16,882 | 13,356 | 75,323 | | | Gross Profit | (945) | 853 | (2,076) | (501) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,938 | 3,531 | 4,226 | 10,506 | | Non Recurring | 14 | (15) | 1 | 3,382 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,875) | (2,663) | (6,303) | (14,389) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,458) | 372 | 1,048 | 922 | | Earnings Before Interest And Taxes | (4,235) | (2,291) | (5,255) | (13,467) | | Interest Expense | 925 | 595 | 865 | 996 | | Income Before Tax | (5,160) | (2,886) | (6,120) | (14,463) | | Income Tax Expense | 34 | (53) |
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,194) | (2,833) | (6,120) | (14,463) | | | Non-recurring Events | | Discontinued Operations | 1,299 | (415) | 14,433 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,895) | (3,248) | 8,313 | (14,463) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,895) | ($3,248) | $8,313 | ($14,463) |
|
1.52% Nasdaq 0.00%
Income Statement
